NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE151581 Query DataSets for GSE151581
Status Public on Apr 07, 2021
Title Temporal evolution of cellular heterogeneity during the progression to advanced, AR-negative prostate cancer [RRBS]
Organisms Homo sapiens; Mus musculus
Experiment type Methylation profiling by high throughput sequencing
Summary Despite advances in the development of highly effective androgen receptor (AR)-directed therapies for the treatment of men with advanced prostate cancer, acquired resistance ultimately ensues. A significant subset of patients with resistant disease develop AR-null, androgen-indifferent tumors that lose their luminal identify and display neuroendocrine features (neuroendocrine prostate cancer (NEPC)). Utilizing a genetically engineered mouse model, we have characterized the synergy between N-Myc overexpression and RB1 loss-of-function which results in the formation of AR-negative, poorly differentiated tumors with high metastatic potential. Single-cell-based approaches revealed striking changes to the transcriptome and chromatin accessibility during the transition to NEPC. Global DNA methylation and the N-Myc cistrome are redirected following RB1 loss. Altogether, our data provide new insight into the progression to NEPC.
 
Overall design RRBS in LNCaP human prostate cancer cells and mouse prostate tumors
 
Contributor(s) Brady NJ, Bagadion AM, Singh R, Rickman DS
Citation(s) 34099734
NIH grant(s)
Grant ID Grant title Affiliation Name
P50 CA211024 Weill Cornell Medicine (WCM) SPORE in Prostate Cancer WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY Massimo Loda
R01 CA230913 Defining Molecular Determinants of Lineage Plasticity as a Mechanism of Treatment Resistance in Prostate Cancer WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY David S Rickman
Submission date Jun 01, 2020
Last update date Jun 09, 2021
Contact name Nicholas Brady
E-mail(s) njb2003@med.cornell.edu
Organization name Weill Cornell Medicine
Department Pathology and Laboratory Medicine
Street address 1188 York Ave
City New York
State/province NY
ZIP/Postal code 10065
Country USA
 
Platforms (2)
GPL24247 Illumina NovaSeq 6000 (Mus musculus)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (8)
GSM4586125 1715_PoorDifferentiation
GSM4586126 1845_Adenocarcinoma
GSM4586127 2266_PoorDifferentiation
This SubSeries is part of SuperSeries:
GSE151426 Temporal evolution of cellular heterogeneity during the progression to advanced, AR-negative prostate cancer
Relations
BioProject PRJNA636399
SRA SRP265512

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE151581_RAW.tar 237.8 Mb (http)(custom) TAR (of TXT)
GSE151581_RRBS_LNCaPNMyc_Vs_LNCaPNMYCShRB1.txt.gz 2.0 Mb (ftp)(http) TXT
GSE151581_RRBS_PoorDiff_Vs_Adeno_Mice.txt.gz 555.0 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap